IndiaMTF — home
Stock

Natco Pharma — MTF Book

NATCOPHARM · Natco Pharma Limited
Health Technology

Daily Margin Trading Facility book for Natco Pharma across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Natco Pharma’s MTF book?

Natco Pharma Limited (NATCOPHARM) has ₹174 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.12% of India’s MTF book, ranking #209. Over 1M (the last 30 trading days) the funded value has fallen 7.8%, with the number of shares under margin down 6.9%.

Funded value
₹174 Cr
as of 23 Oct 2026
Rank in book
#209
2,248 days tracked
Share of book
0.12%
of the whole NSE + BSE book
Peak funded
₹534 Cr
on 03 Aug 2017
Largest single-day addition
+₹533 Cr
on 03 Aug 2017
Largest single-day unwind
−₹533 Cr
on 04 Aug 2017
Free-float market cap
₹7,862 Cr
full market cap ₹15,534 Cr · 50.6% free float · Small cap
MTF share of free float
1.80%
0.8× the median small cap · 2.1× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.97%1.71%2.44%3.18%Feb 2024Oct 2026
View as table: share of free float on margin33 months
Month-end% of free float
23 Oct 20261.796%
30 Sep 20261.979%
31 Aug 20262.015%
31 Jul 20261.705%
30 Jun 20261.896%
29 May 20261.658%
30 Apr 20261.663%
30 Mar 20261.523%
27 Feb 20261.813%
30 Jan 20262.286%
31 Dec 20252.485%
28 Nov 20252.622%
31 Oct 20252.897%
30 Sep 20252.893%
29 Aug 20252.922%
31 Jul 20252.895%
30 Jun 20252.393%
30 May 20252.346%
30 Apr 20251.973%
28 Mar 20251.765%
28 Feb 20251.872%
31 Jan 20252.276%
31 Dec 20242.115%
29 Nov 20242.011%
31 Oct 20241.982%
30 Sep 20241.941%
30 Aug 20241.759%
31 Jul 20241.599%
28 Jun 20241.408%
31 May 20241.502%
30 Apr 20241.379%
28 Mar 20241.228%
29 Feb 20241.238%

Dated events

NSE & BSE split

How NATCOPHARM’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹168 Cr · 96.8%BSE ₹6 Cr · 3.2%

MTF vs Price

Margin-funded outstanding for NATCOPHARM in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹791.85
as of 23 Oct 2026
Price, 1M
−4.2%
adjusted for splits and bonuses
Delivery, 20-day avg
54.1%
of traded volume actually settled
Sessions to unwind
7
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹4−2.3%−2.4%
−43,575
+0.9%unwinding into strength
10D−₹1−0.8%+0.2%
+4,356
−0.4%building as it falls
1M−₹15−7.8%−6.9%
−1,31,735
−4.1%unwinding as it falls
3M+₹10+6.1%+12.2%
+1,93,779
−13.8%building as it falls
6M+₹4+2.4%+10.4%
+1,67,455
−26.1%building as it falls
1Y−₹75−30.2%−30.2%
−7,69,882
−5.1%unwinding as it falls

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where NATCOPHARM has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

NATCOPHARM — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 2026174−₹40.12%209
22 Oct 2026178−₹10.12%208
21 Oct 2026179+₹30.12%207
19 Oct 2026176−₹10.11%211
16 Oct 2026176+₹00.11%214
15 Oct 2026176+₹00.11%210
14 Oct 2026176+₹10.11%210
13 Oct 2026175+₹10.11%214
12 Oct 2026174−₹10.11%213
09 Oct 2026175−₹00.11%209
08 Oct 2026175−₹00.11%208
07 Oct 2026175+₹10.11%216
06 Oct 2026174−₹20.11%216
05 Oct 2026176+₹10.11%213
01 Oct 2026175−₹10.11%215
30 Sep 2026177−₹20.11%215
29 Sep 2026178−₹40.11%214
28 Sep 2026182−₹20.12%207
25 Sep 2026184−₹20.12%204
24 Sep 2026186−₹40.12%203
23 Sep 2026190−₹10.12%189
22 Sep 2026190+₹20.12%189
21 Sep 2026188+₹10.12%191
18 Sep 2026187+₹10.12%193
17 Sep 2026186−₹10.12%198
16 Sep 2026187−₹20.12%198
15 Sep 2026189−₹20.12%197
11 Sep 2026191+₹10.12%195
10 Sep 2026190+₹10.12%195
09 Sep 2026189—0.12%197

NATCOPHARM within Health Technology

Ranked #9 of 61 funded Health Technology stocks, carrying 2.6% of that sector’s margin book. Its 1.80% of free float on margin is 2.0× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
7SUNPHARMASun Pharmaceutical Industries₹2794.2%0.13%−0.4%
8ACUTAASAcutaas Chemicals₹1852.8%1.09%+67.4%
9NATCOPHARMNatco Pharma₹1742.6%1.80%−7.8%
10LUPINLupin Limited₹1452.2%0.27%−14.0%
11MARKSANSMarksans Pharma₹1382.1%1.98%−1.6%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.